Newborn Screening Market By Product Type (Instrument, Consumables), By Test Type (Blood test, Hearing screening test, Heart screening), By Technology (Tandem Mass Spectrometry (TMS), Molecular Assays, Immunoassays and Enzymatic Assays, Hearing Screen Technology, Pulse Oximetry Screening Technology, Others), By End User (Hospitals, Clinical laboratories): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global newborn screening market valued at $ 1,055.24 million in 2021, and is projected to reach $ 2,038.47 million by 2031, registering a CAGR of 6.8% from 2022 to 2031
Newborn screening test is the series of test performed during the first few days of your baby's life, usually by a hospital health care practitioner. A few drops of blood from a heel prick are placed on a special card, called a Guthrie card. this card, along with your baby's details, is mailed to a specialized state laboratory, which will test the blood sample for a variety of health disorders, including CF (cystic fibrosis). Newborn screening in certain states requires two blood samples, one at birth and the other a few weeks later. Newborn screening is essential for detection and early diagnosis of certain genetic, endocrine, and metabolic disorders, and are also tested for hearing loss and critical congenital heart defects (CCHDs).
The major factors that drive the growth of the global newborn screening market include increasing government support for newborn screening and development in screening technology. In addition, high birth rate and increasing incidence of neonatal disease propel the market growth. However, lack of improvement in healthcare infrastructure. Conversely, screening of genetic disorders and emerging market such as Brazil, China and India provide significant opportunities to key players in this market due to increase in birth rates and rise in disposable income.
The global newborn screening market is segmented into test type, technology , product type and region. According to test type, the market is categorized into blood test, hearing screening test, heart screening test. By technology, it is segregated into tandem mass spectrometry (TMS), molecular assay, immunoassays & enzymatic assays, hearing screen technology, pulse oximetry screening technology and others(DNA based assay and electrophoresis). on the basis of end user, the market is bifurcated into hospitals and clinical laboratories. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The major companies profiled in the report include the Ab Sciex LLC (subsidiary of Danaher Corporation), Perkinelmer, Inc., Waters Corporation, Natus Medical Incorporated, Masimo Corporation, Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Covidien Plc, Ge Healthcare (subsidiary of General Electric Company) and Trivitron Healthcare.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the newborn screening market analysis from 2021 to 2031 to identify the prevailing Newborn Screening Market opportunity.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the newborn screening market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global newborn screening market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product Type
Instrument
Consumables
By Test Type
Blood test
Hearing screening test
Heart screening
By Technology
Tandem Mass Spectrometry (TMS)
Molecular Assays
Immunoassays and Enzymatic Assays
Hearing Screen Technology
Pulse Oximetry Screening Technology
Others
By End User
Hospitals
Clinical laboratories
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
Italy
Spain
Rest of Europe
France
U.K.
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
Key Market Players
Ab Sciex LLC
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Covidien Plc
Ge Healthcare
PERKINELMER, INC.
MASIMO CORPORATION
Natus Medical Incorporated
Trivitron Healthcare
Waters Corporation
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: NEWBORN SCREENING MARKET, BY PRODUCT TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Instrument
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Consumables
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- CHAPTER 5: NEWBORN SCREENING MARKET, BY TEST TYPE
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Blood test
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Hearing screening test
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Heart screening
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- CHAPTER 6: NEWBORN SCREENING MARKET, BY TECHNOLOGY
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Tandem Mass Spectrometry (TMS)
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Molecular Assays
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Immunoassays and Enzymatic Assays
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- 6.5 Hearing Screen Technology
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
- 6.6 Pulse Oximetry Screening Technology
- 6.6.1 Key market trends, growth factors and opportunities
- 6.6.2 Market size and forecast, by region
- 6.6.3 Market analysis by country
- 6.7 Others
- 6.7.1 Key market trends, growth factors and opportunities
- 6.7.2 Market size and forecast, by region
- 6.7.3 Market analysis by country
- CHAPTER 7: NEWBORN SCREENING MARKET, BY END USER
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Hospitals
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
- 7.3 Clinical laboratories
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
- CHAPTER 8: NEWBORN SCREENING MARKET, BY REGION
- 8.1 Overview
- 8.1.1 Market size and forecast
- 8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Product Type
- 8.2.3 North America Market size and forecast, by Test Type
- 8.2.4 North America Market size and forecast, by Technology
- 8.2.5 North America Market size and forecast, by End User
- 8.2.6 North America Market size and forecast, by country
- 8.2.6.1 U.S.
- 8.2.6.1.1 Market size and forecast, by Product Type
- 8.2.6.1.2 Market size and forecast, by Test Type
- 8.2.6.1.3 Market size and forecast, by Technology
- 8.2.6.1.4 Market size and forecast, by End User
- 8.2.6.2 Canada
- 8.2.6.2.1 Market size and forecast, by Product Type
- 8.2.6.2.2 Market size and forecast, by Test Type
- 8.2.6.2.3 Market size and forecast, by Technology
- 8.2.6.2.4 Market size and forecast, by End User
- 8.2.6.3 Mexico
- 8.2.6.3.1 Market size and forecast, by Product Type
- 8.2.6.3.2 Market size and forecast, by Test Type
- 8.2.6.3.3 Market size and forecast, by Technology
- 8.2.6.3.4 Market size and forecast, by End User
- 8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Product Type
- 8.3.3 Europe Market size and forecast, by Test Type
- 8.3.4 Europe Market size and forecast, by Technology
- 8.3.5 Europe Market size and forecast, by End User
- 8.3.6 Europe Market size and forecast, by country
- 8.3.6.1 Germany
- 8.3.6.1.1 Market size and forecast, by Product Type
- 8.3.6.1.2 Market size and forecast, by Test Type
- 8.3.6.1.3 Market size and forecast, by Technology
- 8.3.6.1.4 Market size and forecast, by End User
- 8.3.6.2 France
- 8.3.6.2.1 Market size and forecast, by Product Type
- 8.3.6.2.2 Market size and forecast, by Test Type
- 8.3.6.2.3 Market size and forecast, by Technology
- 8.3.6.2.4 Market size and forecast, by End User
- 8.3.6.3 U.K.
- 8.3.6.3.1 Market size and forecast, by Product Type
- 8.3.6.3.2 Market size and forecast, by Test Type
- 8.3.6.3.3 Market size and forecast, by Technology
- 8.3.6.3.4 Market size and forecast, by End User
- 8.3.6.4 Italy
- 8.3.6.4.1 Market size and forecast, by Product Type
- 8.3.6.4.2 Market size and forecast, by Test Type
- 8.3.6.4.3 Market size and forecast, by Technology
- 8.3.6.4.4 Market size and forecast, by End User
- 8.3.6.5 Spain
- 8.3.6.5.1 Market size and forecast, by Product Type
- 8.3.6.5.2 Market size and forecast, by Test Type
- 8.3.6.5.3 Market size and forecast, by Technology
- 8.3.6.5.4 Market size and forecast, by End User
- 8.3.6.6 Rest of Europe
- 8.3.6.6.1 Market size and forecast, by Product Type
- 8.3.6.6.2 Market size and forecast, by Test Type
- 8.3.6.6.3 Market size and forecast, by Technology
- 8.3.6.6.4 Market size and forecast, by End User
- 8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Product Type
- 8.4.3 Asia-Pacific Market size and forecast, by Test Type
- 8.4.4 Asia-Pacific Market size and forecast, by Technology
- 8.4.5 Asia-Pacific Market size and forecast, by End User
- 8.4.6 Asia-Pacific Market size and forecast, by country
- 8.4.6.1 Japan
- 8.4.6.1.1 Market size and forecast, by Product Type
- 8.4.6.1.2 Market size and forecast, by Test Type
- 8.4.6.1.3 Market size and forecast, by Technology
- 8.4.6.1.4 Market size and forecast, by End User
- 8.4.6.2 China
- 8.4.6.2.1 Market size and forecast, by Product Type
- 8.4.6.2.2 Market size and forecast, by Test Type
- 8.4.6.2.3 Market size and forecast, by Technology
- 8.4.6.2.4 Market size and forecast, by End User
- 8.4.6.3 Australia
- 8.4.6.3.1 Market size and forecast, by Product Type
- 8.4.6.3.2 Market size and forecast, by Test Type
- 8.4.6.3.3 Market size and forecast, by Technology
- 8.4.6.3.4 Market size and forecast, by End User
- 8.4.6.4 India
- 8.4.6.4.1 Market size and forecast, by Product Type
- 8.4.6.4.2 Market size and forecast, by Test Type
- 8.4.6.4.3 Market size and forecast, by Technology
- 8.4.6.4.4 Market size and forecast, by End User
- 8.4.6.5 South Korea
- 8.4.6.5.1 Market size and forecast, by Product Type
- 8.4.6.5.2 Market size and forecast, by Test Type
- 8.4.6.5.3 Market size and forecast, by Technology
- 8.4.6.5.4 Market size and forecast, by End User
- 8.4.6.6 Rest of Asia-Pacific
- 8.4.6.6.1 Market size and forecast, by Product Type
- 8.4.6.6.2 Market size and forecast, by Test Type
- 8.4.6.6.3 Market size and forecast, by Technology
- 8.4.6.6.4 Market size and forecast, by End User
- 8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Product Type
- 8.5.3 LAMEA Market size and forecast, by Test Type
- 8.5.4 LAMEA Market size and forecast, by Technology
- 8.5.5 LAMEA Market size and forecast, by End User
- 8.5.6 LAMEA Market size and forecast, by country
- 8.5.6.1 Brazil
- 8.5.6.1.1 Market size and forecast, by Product Type
- 8.5.6.1.2 Market size and forecast, by Test Type
- 8.5.6.1.3 Market size and forecast, by Technology
- 8.5.6.1.4 Market size and forecast, by End User
- 8.5.6.2 Saudi Arabia
- 8.5.6.2.1 Market size and forecast, by Product Type
- 8.5.6.2.2 Market size and forecast, by Test Type
- 8.5.6.2.3 Market size and forecast, by Technology
- 8.5.6.2.4 Market size and forecast, by End User
- 8.5.6.3 South Africa
- 8.5.6.3.1 Market size and forecast, by Product Type
- 8.5.6.3.2 Market size and forecast, by Test Type
- 8.5.6.3.3 Market size and forecast, by Technology
- 8.5.6.3.4 Market size and forecast, by End User
- 8.5.6.4 Rest of LAMEA
- 8.5.6.4.1 Market size and forecast, by Product Type
- 8.5.6.4.2 Market size and forecast, by Test Type
- 8.5.6.4.3 Market size and forecast, by Technology
- 8.5.6.4.4 Market size and forecast, by End User
- CHAPTER 9: COMPANY LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Key developments
- CHAPTER 10: COMPANY PROFILES
- 10.1 Ab Sciex LLC
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
- 10.2 Agilent Technologies Inc.
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
- 10.3 Bio-Rad Laboratories Inc.
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
- 10.4 Covidien Plc
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
- 10.5 Ge Healthcare
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
- 10.6 PERKINELMER, INC.
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
- 10.7 MASIMO CORPORATION
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
- 10.8 Natus Medical Incorporated
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
- 10.9 Trivitron Healthcare
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
- 10.10 Waters Corporation
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 2. NEWBORN SCREENING MARKET REVENUE, FOR INSTRUMENT, BY REGION , 2021-2031,($MILLION)
- TABLE 3. NEWBORN SCREENING MARKET FOR INSTRUMENT BY COUNTRY, 2021-2031,($MILLION)
- TABLE 4. NEWBORN SCREENING MARKET REVENUE, FOR CONSUMABLES, BY REGION , 2021-2031,($MILLION)
- TABLE 5. NEWBORN SCREENING MARKET FOR CONSUMABLES BY COUNTRY, 2021-2031,($MILLION)
- TABLE 6. GLOBAL NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 7. NEWBORN SCREENING MARKET REVENUE, FOR BLOOD TEST, BY REGION , 2021-2031,($MILLION)
- TABLE 8. NEWBORN SCREENING MARKET FOR BLOOD TEST BY COUNTRY, 2021-2031,($MILLION)
- TABLE 9. NEWBORN SCREENING MARKET REVENUE, FOR HEARING SCREENING TEST, BY REGION , 2021-2031,($MILLION)
- TABLE 10. NEWBORN SCREENING MARKET FOR HEARING SCREENING TEST BY COUNTRY, 2021-2031,($MILLION)
- TABLE 11. NEWBORN SCREENING MARKET REVENUE, FOR HEART SCREENING, BY REGION , 2021-2031,($MILLION)
- TABLE 12. NEWBORN SCREENING MARKET FOR HEART SCREENING BY COUNTRY, 2021-2031,($MILLION)
- TABLE 13. GLOBAL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 14. NEWBORN SCREENING MARKET REVENUE, FOR TANDEM MASS SPECTROMETRY (TMS), BY REGION , 2021-2031,($MILLION)
- TABLE 15. NEWBORN SCREENING MARKET FOR TANDEM MASS SPECTROMETRY (TMS) BY COUNTRY, 2021-2031,($MILLION)
- TABLE 16. NEWBORN SCREENING MARKET REVENUE, FOR MOLECULAR ASSAYS, BY REGION , 2021-2031,($MILLION)
- TABLE 17. NEWBORN SCREENING MARKET FOR MOLECULAR ASSAYS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 18. NEWBORN SCREENING MARKET REVENUE, FOR IMMUNOASSAYS AND ENZYMATIC ASSAYS, BY REGION , 2021-2031,($MILLION)
- TABLE 19. NEWBORN SCREENING MARKET FOR IMMUNOASSAYS AND ENZYMATIC ASSAYS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 20. NEWBORN SCREENING MARKET REVENUE, FOR HEARING SCREEN TECHNOLOGY, BY REGION , 2021-2031,($MILLION)
- TABLE 21. NEWBORN SCREENING MARKET FOR HEARING SCREEN TECHNOLOGY BY COUNTRY, 2021-2031,($MILLION)
- TABLE 22. NEWBORN SCREENING MARKET REVENUE, FOR PULSE OXIMETRY SCREENING TECHNOLOGY, BY REGION , 2021-2031,($MILLION)
- TABLE 23. NEWBORN SCREENING MARKET FOR PULSE OXIMETRY SCREENING TECHNOLOGY BY COUNTRY, 2021-2031,($MILLION)
- TABLE 24. NEWBORN SCREENING MARKET REVENUE, FOR OTHERS, BY REGION , 2021-2031,($MILLION)
- TABLE 25. NEWBORN SCREENING MARKET FOR OTHERS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 26. GLOBAL NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 27. NEWBORN SCREENING MARKET REVENUE, FOR HOSPITALS, BY REGION , 2021-2031,($MILLION)
- TABLE 28. NEWBORN SCREENING MARKET FOR HOSPITALS BY COUNTRY, 2021-2031,($MILLION)
- TABLE 29. NEWBORN SCREENING MARKET REVENUE, FOR CLINICAL LABORATORIES, BY REGION , 2021-2031,($MILLION)
- TABLE 30. NEWBORN SCREENING MARKET FOR CLINICAL LABORATORIES BY COUNTRY, 2021-2031,($MILLION)
- TABLE 31. NEWBORN SCREENING MARKET, BY REGION, 2021-2031,($MILLION)
- TABLE 32. NORTH AMERICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 33. NORTH AMERICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 34. NORTH AMERICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 35. NORTH AMERICA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 36. NORTH AMERICA NEWBORN SCREENING MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 37. U.S. NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 38. U.S. NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 39. U.S. NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 40. U.S. NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 41. CANADA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 42. CANADA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 43. CANADA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 44. CANADA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 45. MEXICO NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 46. MEXICO NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 47. MEXICO NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 48. MEXICO NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 49. EUROPE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 50. EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 51. EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 52. EUROPE NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 53. EUROPE NEWBORN SCREENING MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 54. GERMANY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 55. GERMANY NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 56. GERMANY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 57. GERMANY NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 58. FRANCE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 59. FRANCE NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 60. FRANCE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 61. FRANCE NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 62. U.K. NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 63. U.K. NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 64. U.K. NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 65. U.K. NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 66. ITALY NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 67. ITALY NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 68. ITALY NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 69. ITALY NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 70. SPAIN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 71. SPAIN NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 72. SPAIN NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 73. SPAIN NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 74. REST OF EUROPE NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 75. REST OF EUROPE NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 76. REST OF EUROPE NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 77. REST OF EUROPE NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 78. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 79. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 80. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 81. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 82. ASIA-PACIFIC NEWBORN SCREENING MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 83. JAPAN NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 84. JAPAN NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 85. JAPAN NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 86. JAPAN NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 87. CHINA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 88. CHINA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 89. CHINA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 90. CHINA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 91. AUSTRALIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 92. AUSTRALIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 93. AUSTRALIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 94. AUSTRALIA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 95. INDIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 96. INDIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 97. INDIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 98. INDIA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 99. SOUTH KOREA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 100. SOUTH KOREA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 101. SOUTH KOREA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 102. SOUTH KOREA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 103. REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 104. REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 105. REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 106. REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 107. LAMEA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 108. LAMEA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 109. LAMEA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 110. LAMEA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 111. LAMEA NEWBORN SCREENING MARKET, BY COUNTRY, 2021-2031,($MILLION)
- TABLE 112. BRAZIL NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 113. BRAZIL NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 114. BRAZIL NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 115. BRAZIL NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 116. SAUDI ARABIA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 117. SAUDI ARABIA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 118. SAUDI ARABIA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 119. SAUDI ARABIA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 120. SOUTH AFRICA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 121. SOUTH AFRICA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 122. SOUTH AFRICA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 123. SOUTH AFRICA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 124. REST OF LAMEA NEWBORN SCREENING MARKET, BY PRODUCT TYPE, 2021-2031,($MILLION)
- TABLE 125. REST OF LAMEA NEWBORN SCREENING MARKET, BY TEST TYPE, 2021-2031,($MILLION)
- TABLE 126. REST OF LAMEA NEWBORN SCREENING MARKET, BY TECHNOLOGY, 2021-2031,($MILLION)
- TABLE 127. REST OF LAMEA NEWBORN SCREENING MARKET, BY END USER, 2021-2031,($MILLION)
- TABLE 128.AB SCIEX LLC: COMPANY SNAPSHOT
- TABLE 129.AB SCIEX LLC: OPERATING SEGMENTS
- TABLE 130.AB SCIEX LLC: PRODUCT PORTFOLIO
- TABLE 131.AB SCIEX LLC: NET SALES,
- TABLE 132.AB SCIEX LLC: KEY STRATERGIES
- TABLE 133.AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT
- TABLE 134.AGILENT TECHNOLOGIES INC.: OPERATING SEGMENTS
- TABLE 135.AGILENT TECHNOLOGIES INC.: PRODUCT PORTFOLIO
- TABLE 136.AGILENT TECHNOLOGIES INC.: NET SALES,
- TABLE 137.AGILENT TECHNOLOGIES INC.: KEY STRATERGIES
- TABLE 138.BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT
- TABLE 139.BIO-RAD LABORATORIES INC.: OPERATING SEGMENTS
- TABLE 140.BIO-RAD LABORATORIES INC.: PRODUCT PORTFOLIO
- TABLE 141.BIO-RAD LABORATORIES INC.: NET SALES,
- TABLE 142.BIO-RAD LABORATORIES INC.: KEY STRATERGIES
- TABLE 143.COVIDIEN PLC: COMPANY SNAPSHOT
- TABLE 144.COVIDIEN PLC: OPERATING SEGMENTS
- TABLE 145.COVIDIEN PLC: PRODUCT PORTFOLIO
- TABLE 146.COVIDIEN PLC: NET SALES,
- TABLE 147.COVIDIEN PLC: KEY STRATERGIES
- TABLE 148.GE HEALTHCARE: COMPANY SNAPSHOT
- TABLE 149.GE HEALTHCARE: OPERATING SEGMENTS
- TABLE 150.GE HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 151.GE HEALTHCARE: NET SALES,
- TABLE 152.GE HEALTHCARE: KEY STRATERGIES
- TABLE 153.PERKINELMER, INC.: COMPANY SNAPSHOT
- TABLE 154.PERKINELMER, INC.: OPERATING SEGMENTS
- TABLE 155.PERKINELMER, INC.: PRODUCT PORTFOLIO
- TABLE 156.PERKINELMER, INC.: NET SALES,
- TABLE 157.PERKINELMER, INC.: KEY STRATERGIES
- TABLE 158.MASIMO CORPORATION: COMPANY SNAPSHOT
- TABLE 159.MASIMO CORPORATION: OPERATING SEGMENTS
- TABLE 160.MASIMO CORPORATION: PRODUCT PORTFOLIO
- TABLE 161.MASIMO CORPORATION: NET SALES,
- TABLE 162.MASIMO CORPORATION: KEY STRATERGIES
- TABLE 163.NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
- TABLE 164.NATUS MEDICAL INCORPORATED: OPERATING SEGMENTS
- TABLE 165.NATUS MEDICAL INCORPORATED: PRODUCT PORTFOLIO
- TABLE 166.NATUS MEDICAL INCORPORATED: NET SALES,
- TABLE 167.NATUS MEDICAL INCORPORATED: KEY STRATERGIES
- TABLE 168.TRIVITRON HEALTHCARE: COMPANY SNAPSHOT
- TABLE 169.TRIVITRON HEALTHCARE: OPERATING SEGMENTS
- TABLE 170.TRIVITRON HEALTHCARE: PRODUCT PORTFOLIO
- TABLE 171.TRIVITRON HEALTHCARE: NET SALES,
- TABLE 172.TRIVITRON HEALTHCARE: KEY STRATERGIES
- TABLE 173.WATERS CORPORATION: COMPANY SNAPSHOT
- TABLE 174.WATERS CORPORATION: OPERATING SEGMENTS
- TABLE 175.WATERS CORPORATION: PRODUCT PORTFOLIO
- TABLE 176.WATERS CORPORATION: NET SALES,
- TABLE 177.WATERS CORPORATION: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.NEWBORN SCREENING MARKET SEGMENTATION
- FIGURE 2.NEWBORN SCREENING MARKET,2021-2031
- FIGURE 3.NEWBORN SCREENING MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.NEWBORN SCREENING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.NEWBORN SCREENING MARKET,BY PRODUCT TYPE,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF INSTRUMENT NEWBORN SCREENING MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF CONSUMABLES NEWBORN SCREENING MARKET,2021-2031(%)
- FIGURE 15.NEWBORN SCREENING MARKET,BY TEST TYPE,2021(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF BLOOD TEST NEWBORN SCREENING MARKET,2021-2031(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF HEARING SCREENING TEST NEWBORN SCREENING MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HEART SCREENING NEWBORN SCREENING MARKET,2021-2031(%)
- FIGURE 19.NEWBORN SCREENING MARKET,BY TECHNOLOGY,2021(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF TANDEM MASS SPECTROMETRY (TMS) NEWBORN SCREENING MARKET,2021-2031(%)
- FIGURE 21.COMPARATIVE SHARE ANALYSIS OF MOLECULAR ASSAYS NEWBORN SCREENING MARKET,2021-2031(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF IMMUNOASSAYS AND ENZYMATIC ASSAYS NEWBORN SCREENING MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF HEARING SCREEN TECHNOLOGY NEWBORN SCREENING MARKET,2021-2031(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF PULSE OXIMETRY SCREENING TECHNOLOGY NEWBORN SCREENING MARKET,2021-2031(%)
- FIGURE 25.COMPARATIVE SHARE ANALYSIS OF OTHERS NEWBORN SCREENING MARKET,2021-2031(%)
- FIGURE 26.NEWBORN SCREENING MARKET,BY END USER,2021(%)
- FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HOSPITALS NEWBORN SCREENING MARKET,2021-2031(%)
- FIGURE 28.COMPARATIVE SHARE ANALYSIS OF CLINICAL LABORATORIES NEWBORN SCREENING MARKET,2021-2031(%)
- FIGURE 29.NEWBORN SCREENING MARKET BY REGION,2021
- FIGURE 30.U.S. NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 31.CANADA NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 32.MEXICO NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 33.GERMANY NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 34.FRANCE NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 35.U.K. NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 36.ITALY NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 37.SPAIN NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 38.REST OF EUROPE NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 39.JAPAN NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 40.CHINA NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 41.AUSTRALIA NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 42.INDIA NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 43.SOUTH KOREA NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 44.REST OF ASIA-PACIFIC NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 45.BRAZIL NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 46.SAUDI ARABIA NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 47.SOUTH AFRICA NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 48.REST OF LAMEA NEWBORN SCREENING MARKET,2021-2031($MILLION)
- FIGURE 49. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 50. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 51. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 52.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 53.COMPETITIVE DASHBOARD
- FIGURE 54.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 55.AB SCIEX LLC.: NET SALES ,($MILLION)
- FIGURE 56.AGILENT TECHNOLOGIES INC..: NET SALES ,($MILLION)
- FIGURE 57.BIO-RAD LABORATORIES INC..: NET SALES ,($MILLION)
- FIGURE 58.COVIDIEN PLC.: NET SALES ,($MILLION)
- FIGURE 59.GE HEALTHCARE.: NET SALES ,($MILLION)
- FIGURE 60.PERKINELMER, INC..: NET SALES ,($MILLION)
- FIGURE 61.MASIMO CORPORATION.: NET SALES ,($MILLION)
- FIGURE 62.NATUS MEDICAL INCORPORATED.: NET SALES ,($MILLION)
- FIGURE 63.TRIVITRON HEALTHCARE.: NET SALES ,($MILLION)
- FIGURE 64.WATERS CORPORATION.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook